Article
Mice carrying the human dopamine D2 receptor pathogenic mutation p.Met374Arg exhibit hyperactivity and aberrant D2 receptor function.
Molecular pharmacology - 1 Nov 2025
Rodriguez-Contreras Dayana, Lebowitz Joseph J, Reed Cheryl, Walker-Ziegler Elizabeth, Buck David C, Li Guochuan, Xie Shu, Li Yulong, Fedorov Lev M, Phillips Tamara J, Williams John T, Neve Kim A
Abstract excerpt
Two human dopamine D2 receptor mutations cause dominant hyperkinetic movement disorders. The phenotype of carriers of the DRD2 variant c.634A>T, p.Ile212Phe (D2-I212F) is less severe than that of carriers of the variant c.1121 T>G, p.Met374Arg (D2-M6.36R). Both are gain-of-function mutations with respect to G protein-mediated signaling; however, D2-M6.36R exhibits greater gain-of-function than D2-I212F,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
